Detalhe da pesquisa
1.
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Circulation
; 136(10): 907-916, 2017 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28655834
2.
Acid control cannot be improved with a modified-release formulation of a proton pump inhibitor compared with twice-daily dosing of the conventional formulation.
Dig Dis Sci
; 55(12): 3423-9, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20238247
3.
Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects.
Clin Drug Investig
; 37(11): 1035-1045, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28856602